Deep Track Capital, LP - Q4 2016 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2016
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRAVERE THERAPEUTICS INC11Q2 20245.7%
IMMUNOVANT INC11Q2 20247.2%
BICYCLE THERAPEUTICS PLC11Q2 20245.2%
4D MOLECULAR THERAPEUTICS IN11Q2 20242.9%
DYNE THERAPEUTICS INC11Q2 20244.2%
VIRIDIAN THERAPEUTICS INC11Q2 20242.6%
REPARE THERAPEUTICS INC11Q2 20243.1%
SILENCE THERAPEUTICS PLC11Q2 20241.6%
VIGIL NEUROSCIENCE INC10Q2 20241.1%
RELMADA THERAPEUTICS INC10Q2 20240.8%

View Deep Track Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Deep Track Capital, LP Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Context Therapeutics Inc.May 10, 20247,419,3559.9%
INOVIO PHARMACEUTICALS, INC.April 26, 20242,593,82210.0%
Korro Bio, Inc.April 26, 2024714,2857.7%
Zura Bio LtdApril 22, 20246,216,3279.3%
Guardant Health, Inc.April 12, 20247,000,0005.8%
Avalo Therapeutics, Inc.April 05, 2024114,77510.0%
CYBIN INC.March 22, 202458,139,5357.6%
Olema Pharmaceuticals, Inc.March 22, 20243,040,2485.4%
Regulus Therapeutics Inc.March 22, 20246,888,42410.0%
Mind Medicine (MindMed) Inc.March 15, 20246,666,6679.5%

View Deep Track Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-09-23
SC 13D2024-09-16
N-PX2024-08-15
13F-HR2024-08-14
SC 13G2024-07-12
SC 13G2024-07-02
13F-HR2024-05-15
42024-05-13
SC 13G2024-05-10
SC 13G2024-04-26

View Deep Track Capital, LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Deep Track Capital, LP's holdings

CSVXLS